3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
6
Recruiting
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Glioblastoma
12
Prostatic Neoplasms
11
Breast Neoplasms
10
Lung Neoplasms
9
Carcinoma, Non-Small-Cell Lung
9
Neoplasm Metastasis
7
Squamous Cell Carcinoma of Head and Neck
6
Sarcoma
5
Oropharyngeal Neoplasms
5
Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Head and Neck Neoplasms
4
Brain Neoplasms
4
Astrocytoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Melanoma
3
Liposarcoma
3
Leiomyosarcoma
3
Hodgkin Disease
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma, Hepatocellular
3
Adenocarcinoma Of Esophagus
3
Stomach Neoplasms
2
Sarcoma, Ewing
2
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Interventions
pembrolizumab
15
Paclitaxel
15
Carboplatin
13
Specimen Handling
6
Biopsy
6
durvalumab
5
Magnetic Resonance Spectroscopy
5
dostarlimab
4
Taxes
4
Surveys and Questionnaires
4
Observation
4
Letrozole
4
Everolimus
4
Cisplatin
4
olaparib
3
lenvatinib
3
ceralasertib
3
Doxorubicin
3
sacituzumab govitecan
2
pertuzumab
2
copanlisib
2
cabozantinib
2
atezolizumab
2
abemaciclib
2
Trastuzumab
2
Robotic Surgical Procedures
2
Pemetrexed
2
Nivolumab
2
Metformin
2
Megestrol Acetate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Endometrial Neoplasms
×
Radiation
×
Clear all
NCT05139368
2024-11-18
RT-PACE
University of Utah
Phase NA
Active not recruiting
22 enrolled